Penbrook Management’s Chembio diagnostics, Inc. CEMI Stock Holding History

Penbrook Management’s Portfolio CEMI Stock Details CEMI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-83,450	Closed	-$68K	–	112
2022 Q1	$68K	Sell	83,450 -112,660	-57%	-$105K	0.04%	108
2021 Q4	$224K	Sell	196,110 -158,560	-45%	-$323K	0.14%	94
2021 Q3	$887K	Sell	354,670 -600	-0.2%	-$1.66K	0.55%	57
2021 Q2	$1.05M	Buy	355,270 +6,310	+2%	+$22K	0.63%	51
2021 Q1	$1.23M	Buy	348,960 +4,900	+1%	+$27.3K	0.88%	38
2020 Q4	$1.63M	Buy	344,060 +1,300	+0.4%	+$6.71K	1.26%	23
2020 Q3	$1.67M	Buy	342,760 +120,540	+54%	+$571K	1.44%	19
2020 Q2	$722K	Buy	222,220 +24,660	+12%	+$234K	0.71%	42
2020 Q1	$1.01M	Buy	197,560 +33,920	+21%	+$137K	1.29%	24
2019 Q4	$746K	Buy	163,640 +39,690	+32%	+$193K	0.73%	49
2019 Q3	$758K	Sell	123,950 -1,500	-1%	-$8.94K	0.82%	45
2019 Q2	$764K	Sell	125,450 -2,200	-2%	-$14.8K	0.82%	43
2019 Q1	$709K	Buy	+127,650	New	+$829K	0.74%	47

Other funds holding CEMI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Penbrook Management's CEMI Position: Q2 2022 in Review

Penbrook Management sold out of Chembio diagnostics, Inc. (CEMI) in Q2 2022, closing a stake of 83,450 shares — an estimated $68K sold.

Penbrook Management first reported a position in CEMI in Q1 2019 and held it in 13 quarters. The position peaked at $1.67M in Q3 2020. 38 funds tracked by Wall St. Rank hold CEMI as of Q2 2022.

Penbrook Management reported no remaining Chembio diagnostics, Inc. position as of Q2 2022 after selling out during the quarter.
Penbrook Management sold 83,450 Chembio diagnostics, Inc. shares in Q2 2022, an estimated $68K.
Penbrook Management first reported a position in Chembio diagnostics, Inc. in Q1 2019 and held it in 13 quarters.
Penbrook Management's Chembio diagnostics, Inc. position peaked at $1.67M in Q3 2020.
38 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q2 2022.

Based on Penbrook Management's 13F filing for Q2 2022, filed 29 Jul 2022.